Market Access Views & Analysis

Views & Analysis

Deep Dive: Market Access - Breaking Barriers

In this issue of Deep Dive we look at the changing landscape for pharma market access and start to assess the impact of the COVID-19 pandemic.

Views & Analysis

6 ways to digitise your business at pace

As the COVID-19 pandemic stretches on, can your business survive without face-to-face customer contact?

Views & Analysis

Coronavirus pharma news roundup 15/5/20

This week saw some mixed news in coronavirus research as questions were raised about access to COVID-19 drugs as studies – and approvals – continued apace.

Views & Analysis

What COVID-19 means for generics companies

Generics companies have found themselves at the forefront of fighting COVID-19 – but it has required rapid change at all levels of the business.

Views & Analysis

Coronavirus pharma news roundup – 1/5/2020

This week saw several pharma companies reveal how the coronavirus pandemic has affected their sales.

Views & Analysis

Daiichi Sankyo: pharma needs to become NHS ‘experts’

If pharma wants to help the NHS improve outcomes, it needs to do so through a true partnership rather than a transactional relationship.

Deep Dive: Market Access - Breaking Barriers

6 ways to digitise your business at pace

Coronavirus pharma news roundup 15/5/20

What COVID-19 means for generics companies

Coronavirus pharma news roundup – 1/5/2020

Daiichi Sankyo: pharma needs to become NHS ‘experts’

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Views & Analysis

Editor's Picks